122 related articles for article (PubMed ID: 37075613)
1. Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels.
Bahlmann LC; Xue C; Chin AA; Skirzynska A; Lu J; Thériault B; Uehling D; Yerofeyeva Y; Peters R; Liu K; Chen J; Martel AL; Yaffe M; Al-Awar R; Goswami RS; Ylanko J; Andrews DW; Kuruvilla J; Laister RC; Shoichet MS
Biomaterials; 2023 Jun; 297():122121. PubMed ID: 37075613
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
Locatelli SL; Careddu G; Serio S; Consonni FM; Maeda A; Viswanadha S; Vakkalanka S; Castagna L; Santoro A; Allavena P; Sica A; Carlo-Stella C
Clin Cancer Res; 2019 Feb; 25(3):1098-1112. PubMed ID: 30352904
[TBL] [Abstract][Full Text] [Related]
3. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.
Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E
Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066
[TBL] [Abstract][Full Text] [Related]
4. The effect of PD-1 expression on tumor-associated macrophage in T cell lymphoma.
Ruan J; Ouyang M; Zhang W; Luo Y; Zhou D
Clin Transl Oncol; 2021 Jun; 23(6):1134-1141. PubMed ID: 33211280
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition.
Baumann D; Drebant J; Hägele T; Burger L; Serger C; Lauenstein C; Dudys P; Erdmann G; Offringa R
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34285105
[TBL] [Abstract][Full Text] [Related]
6. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor γ activation.
Zhang O; Zhang J
Int Immunopharmacol; 2015 May; 26(1):58-64. PubMed ID: 25794645
[TBL] [Abstract][Full Text] [Related]
8. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D
Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135
[TBL] [Abstract][Full Text] [Related]
9. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
J Pharmacol Exp Ther; 2009 Jun; 329(3):856-64. PubMed ID: 19286921
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Van Den Neste E; André M; Gastinne T; Stamatoullas A; Haioun C; Belhabri A; Reman O; Casasnovas O; Ghesquieres H; Verhoef G; Claessen MJ; Poirel HA; Copin MC; Dubois R; Vandenberghe P; Stoian IA; Cottereau AS; Bailly S; Knoops L; Morschhauser F
Haematologica; 2018 May; 103(5):840-848. PubMed ID: 29351986
[TBL] [Abstract][Full Text] [Related]
11. Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
Ju W; Zhang M; Wilson KM; Petrus MN; Bamford RN; Zhang X; Guha R; Ferrer M; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1624-9. PubMed ID: 26811457
[TBL] [Abstract][Full Text] [Related]
12. PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.
Cheng Y; Zhu Y; Xu W; Xu J; Yang M; Chen P; Zhao J; Geng L; Gong S
Mol Carcinog; 2018 Aug; 57(8):1017-1029. PubMed ID: 29637628
[TBL] [Abstract][Full Text] [Related]
13. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.
Bi S; Huang W; Chen S; Huang C; Li C; Guo Z; Yang J; Zhu J; Song L; Yu R
Int J Biol Macromol; 2020 May; 150():261-280. PubMed ID: 32044366
[TBL] [Abstract][Full Text] [Related]
14. M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma.
Shen L; Li H; Shi Y; Wang D; Gong J; Xun J; Zhou S; Xiang R; Tan X
Sci Rep; 2016 Jul; 6():30347. PubMed ID: 27464733
[TBL] [Abstract][Full Text] [Related]
15. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
[TBL] [Abstract][Full Text] [Related]
16. The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients.
Procházka V; Papajík T; Dýšková T; Dihel M; Brychtová S; Prouzová Z; Kriegová E; Lukášová M; Hanáčková V
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):e573-e580. PubMed ID: 31377208
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
18. Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
Kim SJ; Yoon DH; Kang HJ; Hong JY; Lee HS; Oh SY; Shin HJ; Kong JH; Yi JH; Sakamoto K; Ko YH; Huh J; Lee SS; Takeuchi K; Shin DY; Suh C; Kim WS
BMC Cancer; 2019 Nov; 19(1):1080. PubMed ID: 31707975
[TBL] [Abstract][Full Text] [Related]
19. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway.
Lin L; Jin Y; Hu K
J Biol Chem; 2015 Mar; 290(12):7910-7. PubMed ID: 25670857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
